Theoretical and Experimental Investigation of Functionalized Cyanopyridines Yield an Anolyte with an Extremely Low Reduction Potential for Nonaqueous Redox Flow Batteries.

Cyanopyridines and cyanophenylpyridines were investigated as anolytes for nonaqueous redox flow batteries (RFBs). The three isomers of cyanopyridine are reduced at potentials of -2.2 V or lower vs. ferrocene+/0 (Fc+/0 ), but the 3-CNPy⋅- radical anion forms a sigma-dimer that is re-oxidized at E≈-1.1 V, which would lead to poor voltaic efficiency in a RFB. Bulk electrochemical charge-discharge cycling of the cyanopyridines in acetonitrile and 0.50 M [NBu4 ][PF6 ] shows that 2-CNPy and 4-CNPy lose capacity quickly under these conditions, due to irreversible chemical reaction/decomposition of the radical anions. Density-functional theory (DFT) calculations indicated that adding a phenyl group to the cyanopyridines would, for some isomers, limit dimerization and improve the stability of the radical anions, while shifting their E1/2 only about +0.10 V relative to the parent cyanopyridines. Among the cyanophenylpyridines, 3-CN-6-PhPy and 3-CN-4-PhPy are the most promising as anolytes. They exhibit reversible reductions at E1/2 =-2.19 and -2.22 V vs. ferrocene+/0 , respectively, and retain about half of their capacity after 30 bulk charge-discharge cycles. An improved version of 3-CN-6-PhPy with three methyl groups (3-cyano-4-methyl-6-(3,5-dimethylphenyl)pyridine) has an extremely low reduction potential of -2.50 V vs. Fc+/0 (the lowest reported for a nonaqueous RFB anolyte) and loses only 0.21 % of capacity per cycle during charge-discharge cycling in acetonitrile.

Akt switches TopBP1 function from checkpoint activation to transcriptional regulation through phosphoserine binding-mediated oligomerization.

Our previous study showed that Akt phosphorylates TopBP1 at the Ser-1159 residue and induces its oligomerization. Oligomerization is required for TopBP1 to bind and repress E2F1 activity. However, the mechanism through which phosphorylation of TopBP1 by Akt leads to its oligomerization remains to be determined. Here, we demonstrate that binding between the phosphorylated Ser-1159 (pS1159) residue and the 7th and 8th BRCT domains of TopBP1 mediates TopBP1 oligomerization. Mutations within the 7th and 8th BRCT domains of TopBP1 that block binding to a pS1159-containing peptide block TopBP1 oligomerization and its ability to bind and repress E2F1 activities. The Akt-induced TopBP1 oligomerization is also directly demonstrated in vitro by size exclusion chromatography. Importantly, oligomerization perturbs the checkpoint-activating function of TopBP1 by preventing its recruitment to chromatin and ATR binding upon replicative stress. Hyperactivation of Akt inhibits Chk1 phosphorylation after hydroxyurea treatment, and this effect is dependent on TopBP1 phosphorylation at Ser-1159. Thus, Akt can switch the TopBP1 function from checkpoint activation to transcriptional regulation by regulating its quaternary structure. This pathway of regulation is clinically significant, since treatment of a specific Akt inhibitor in PTEN-mutated cancer cells inhibits TopBP1 oligomerization and causes its function to revert from promoting survival to checkpoint activation.